Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
Biochim Biophys Acta ; 1647(1-2): 88-91, 2003 Apr 11.
Article in English | MEDLINE | ID: mdl-12686114

ABSTRACT

Patients with diabetes mellitus and with vascular complications in particular, exhibit higher plasma activities of semicarbazide-sensitive amine oxidase (SSAO) compared to control subjects. It has been speculated that production of cytotoxic products of SSAO may cause endothelial damage and thus contribute to the development of diabetic vascular complications such as retino-, nephro-, and neuropathies as a result of SSAO activity.In order to explore the possibility that high SSAO activity contributes to the development of vascular complications in diabetes, we have performed two studies in patients with Type-2 diabetes quantifying plasma SSAO activity, HbA(1c), and urinary levels of the SSAO substrate, methylamine. We also examined the prevalence of retinopathy in these patients. Additionally, we have studied a model of transgenic mice expressing human SSAO in smooth muscle cells. The transgenic mice have an increased SSAO activity as well as mRNA expression. Histological studies revealed a specific aorta phenotype with a condensed and rigid vessel wall in some of the transgenic mice. No wild-type animals displayed this phenotype.In conclusion, we suggest that this transgenic mouse model may be of great value for increasing the knowledge about to what extent human SSAO contributes to vascular complications in diabetes, and also to which extent inhibition of SSAO can prevent the development of such complications.


Subject(s)
Amine Oxidase (Copper-Containing)/blood , Diabetes Mellitus, Type 2/enzymology , Diabetic Retinopathy/enzymology , Semicarbazides/pharmacology , Amine Oxidase (Copper-Containing)/genetics , Animals , Diabetes Mellitus, Type 2/complications , Humans , Mice , Mice, Transgenic
2.
J Neural Transm (Vienna) ; 109(5-6): 963-75, 2002 May.
Article in English | MEDLINE | ID: mdl-12111482

ABSTRACT

Platelet monoamine oxidase (MAO) activity has been shown to be inversely associated with personality traits such as sensation seeking, impulsiveness and extraversion. Those personality traits have also been linked to vulnerability for substance abuse, e.g. tobacco smoking and early onset or "type 2" alcoholism. Compounds in cigarette smoke have been shown to be inhibitors of MAO, which has led several authors to claim that there is no association between alcoholism, which is the most studied psychiatric condition, and platelet MAO if the effect of smoking is removed. With regard to the association between personality and platelet MAO, authors have in general been cautious. In the present paper we describe a number of results which show that there is such an association, both in clinical series if the effect of smoking is removed and in series where smoking have never taken place. A cornerstone in this regard is the significant association between platelet MAO activity and both behaviour/personality, voluntary alcohol intake and biochemical measures of CNS serotonergic activity in non-human primates. Strong evidence that the regulation of platelet MAO activity takes place on a transcriptional level with an involvement of transcription factors, likely to also regulate central monoaminergic activity, are presented.


Subject(s)
Blood Platelets/enzymology , Monoamine Oxidase/blood , Personality , Smoking , DNA-Binding Proteins/physiology , Humans , Mental Disorders/blood , Transcription Factor AP-2 , Transcription Factors/physiology , Transcription, Genetic/physiology
3.
Mol Psychiatry ; 6(5): 503-10, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11526464

ABSTRACT

Major changes in psychiatric phenotypes due to genetic factors are seldom the result of single gene polymorphisms, but more often the result of several genetic mechanisms. In this millennium article we discuss the notion that the expression of numerous candidate genes could be regulated by the same transcription factors, and that polymorphisms in transcription factor genes might explain some phenotypes. We describe recent results of studies on the biological marker thrombocyte monoamine oxidase (trbc MAO) and the transcription factor AP-2beta. Low levels of trbc MAO is associated with temperamental characteristics such as sensation seeking and impulsiveness, and the enzyme is genetically regulated by specific transcriptional mechanisms. Transcription factor AP-2beta is important for the development of midbrain structures and AP-2beta has several binding sites in the regulatory regions of genes encoding key proteins in the monoamine transmitter systems. We have recently shown AP-2beta to be linked to personality, binge-eating disorder, treatment with antidepressant drugs, and also to trbc MAO. Regardless of whether transcriptions factors, such as AP-2beta, regulate the expression of eg, the number of monoamine neurons or a variety of candidate genes within the monoamine systems, or both, we would like to emphasize the role of transcription factors, besides polymorphisms in monoaminergic candidate genes, when explaining inter-individual differences in temperament and psychiatric vulnerability.


Subject(s)
Behavior/physiology , Gene Expression Regulation , Mental Disorders/genetics , Personality Disorders/genetics , Transcription Factors/genetics , Transcription Factors/metabolism , Animals , Behavior, Animal/physiology , Humans , Polymorphism, Genetic
4.
J Diabetes Complications ; 15(5): 250-6, 2001.
Article in English | MEDLINE | ID: mdl-11522499

ABSTRACT

Plasma activity of the enzyme semicarbazide-sensitive amine oxidase (SSAO) is high in diabetes. Production of angiotoxic substances (an aldehyde, hydrogen peroxide, and ammonia) in vessel walls is catalysed by SSAO, suggesting a role for SSAO in the development of complications of diabetes. The objective of the present study was to follow up plasma SSAO activity (measured radiometrically), HbA(1c) (using ion exchange chromatography), and retinopathy (by fundus photography) after 2.8 years, in 34 patients with Type 2 diabetes. We also measured urinary levels of an SSAO substrate, methylamine, by fluorometric high-performance liquid chromatography (HPLC). As at baseline, plasma SSAO activity was now higher in subjects with retinopathy (mean 19.5) than in subjects without retinopathy (mean 16.0), 95% confidence interval (CI) for difference 0.6-6.3 nmol benzylamine ml(-1) plasma h(-1). SSAO activity had not changed significantly since baseline, mean difference -1.65 and 95% CI for difference -3.76 to 0.46 nmol benzylamine ml(-1) plasma h(-1). Mean HbA(1c) level remained higher for patients with retinopathy (now 7.9%) compared to those without retinopathy (6.1%), 95% CI for difference 0.6-3.0%. Comparing baseline and the present study, retinopathy was nonproliferative; level had worsened for five and improved for two patients. Urinary methylamine/creatinine ratio was lower in the group of patients with retinopathy (mean 0.99) than in those without retinopathy (mean 1.78), 95% CI for difference 0.1-1.5 microg mg(-1). The results of the present study are compatible with a role for SSAO in the development of diabetic retinopathy.


Subject(s)
Amine Oxidase (Copper-Containing)/blood , Diabetes Mellitus, Type 2/blood , Diabetic Retinopathy/blood , Diabetic Retinopathy/pathology , Aged , Creatinine/blood , Creatinine/urine , Diabetes Mellitus, Type 2/urine , Diabetic Retinopathy/urine , Female , Follow-Up Studies , Fundus Oculi , Glycated Hemoglobin/analysis , Humans , Male , Methylamines/urine , Middle Aged , Photography
5.
Behav Neurosci ; 115(2): 358-64, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11345960

ABSTRACT

Biological markers for acquisition and extinction of fear conditioning were studied in 40 individuals selected for displaying either good or poor acquisition of fear conditioning. as estimated by the skin conductance response. Participants with a short serotonin transporter (5-HTT) promoter allele or low monoamine oxidase activity in platelets (trbc-MAO) displayed better acquisition than those with only long alleles or high trbc-MAO, whereas participants with a long dopamine D4 receptor (D4DR) exon III allele showed delayed extinction compared with those with only short alleles. The findings, that D4DR exon III and 5-HTT promoter genotypes and trbc-MAO activity are related to human fear conditioning, a basic form of associative learning, are consistent with animal studies suggesting a genetic contribution to fear conditioning. The authors suggest that in humans these genetic mechanisms are partly dopaminergic and serotonergic in origin.


Subject(s)
Arousal/physiology , Conditioning, Classical/physiology , Dopamine/physiology , Fear/physiology , Membrane Transport Proteins , Nerve Tissue Proteins , Serotonin/physiology , Alleles , Association Learning/physiology , Biomarkers/blood , Blood Platelets/enzymology , Carrier Proteins/genetics , Galvanic Skin Response/physiology , Genotype , Humans , Membrane Glycoproteins/genetics , Mental Recall/physiology , Monoamine Oxidase/blood , Promoter Regions, Genetic/genetics , Receptors, Dopamine D2/genetics , Receptors, Dopamine D4 , Serotonin Plasma Membrane Transport Proteins
6.
J Neural Transm (Vienna) ; 107(5): 523-30, 2000.
Article in English | MEDLINE | ID: mdl-11072748

ABSTRACT

Monoamine oxidases (MAO) play a critical role in the degradation of endogenous and exogenous amines throughout the body. There are two distinct MAO isoforms, MAO-A and MAO-B, which both are encoded in genes on the X chromosome. Alterations in MAO-B activity have previously been connected with several neurological disorders. Platelet MAO (trbc-MAO) is exclusively of the B-type and the catalytic activity of this enzyme is under strong, yet unknown, genetic control. Specific trbc-MAO activity has been reported to be increased in certain neurodegenerative diseases and to correlate with personality traits such as sensation seeking and impulsiveness. In the present study, we investigated if trbc-MAO activity is associated with genotype at a variable region (A/G dimorphism) in intron 13 of the human gene encoding MAO-B. The MAOB intron 13 allele status and levels of trbc-MAO were determined for 55 Caucasian non-smoking males. Individuals with the "A-allele" displayed significantly lower enzyme activity than individuals with the "G-allele", i.e. 11.4 +/- 0.6 nmol/10(10) platelets/min compared with 13.5 +/- 0.6 (mean +/- SEM, p = 0.019). The present results suggest that the MAOB genotype may be involved in determining trbc-MAO activity.


Subject(s)
Blood Platelets/enzymology , Introns/genetics , Monoamine Oxidase/genetics , Polymorphism, Genetic/genetics , Adult , Analysis of Variance , Genotype , Humans , Male , Monoamine Oxidase/metabolism
7.
Neurobiology (Bp) ; 8(2): 129-35, 2000.
Article in English | MEDLINE | ID: mdl-11061210

ABSTRACT

Semicarbazide-sensitive amine oxidases (SSAOs) are widely expressed copper-containing enzymes. One enzyme of this family have high specific activity towards benzylamine and is present in human blood plasma. This enzyme is altered in several diseases, for instance in diabetes. Presently it is unclear where the plasma SSAO is synthesized. Previous autoradiographic studies have suggested that SSAO may be expressed in bone tissue. In the current study we have analyzed levels of SSAO in serum from cases with 'skeletal disease', i.e. patients with severe skeletal metastases of prostate cancer and subjects having recent fractures. Interestingly, subjects with metastases showed significantly elevated levels of SSAO in serum compared to individuals having prostate cancer without skeletal metastases. It is speculated that, at least in part, SSAO in the blood stream may be derived from bone tissue.


Subject(s)
Adenocarcinoma/pathology , Amine Oxidase (Copper-Containing)/blood , Bone Neoplasms/pathology , Bone and Bones/enzymology , Fractures, Bone/blood , Prostatic Neoplasms/secondary , Adenocarcinoma/blood , Adenocarcinoma/diagnostic imaging , Adult , Aged , Aged, 80 and over , Bone Neoplasms/blood , Bone Neoplasms/diagnostic imaging , Bone and Bones/pathology , Female , Fractures, Bone/diagnostic imaging , Humans , Male , Middle Aged , Prostatic Neoplasms/blood , Prostatic Neoplasms/diagnostic imaging , Radionuclide Imaging
8.
Neurobiology (Bp) ; 8(2): 167-77, 2000.
Article in English | MEDLINE | ID: mdl-11061213

ABSTRACT

Under the influence of semicarbazide-sensitive amine oxidase (SSAO), methylamine is deaminated to formaldehyde, which can react with various macromolecules and form irreversible adducts. We hereby present an autoradiographic method of visualising SSAO activity by measuring the in vivo formation of such adducts from 14C-methylamine. Our results revealed high concentrations of radioactive deposits in the intestinal wall, brown adipose tissue, spleen and bone marrow. Hydralazine is a potent SSAO inhibitor and pretreatment with this irreversible inactivator resulted in a nearly complete loss of radioactive deposits in the tissues. By giving 14C-methylamine at different time-points after irreversible inhibition of SSAO, it was also possible to determine the resynthesis rate of SSAO. Interestingly, the recovery rate of SSAO after such inactivation was tissue-specific. The possible therapeutic value of a specific SSAO inhibitory drug has been discussed.


Subject(s)
Amine Oxidase (Copper-Containing)/analysis , Autoradiography/methods , Salivary Glands/enzymology , Testis/enzymology , Amine Oxidase (Copper-Containing)/antagonists & inhibitors , Animals , Antihypertensive Agents/pharmacology , Brain/enzymology , Carbon Radioisotopes , Hydralazine/pharmacology , Kidney/enzymology , Liver/enzymology , Lung/enzymology , Male , Methylamines , Mice , Mice, Inbred Strains , Monoamine Oxidase/metabolism , Muscle, Skeletal/enzymology , Myocardium/enzymology , Pancreas/enzymology , Spleen/enzymology
9.
Neurosci Lett ; 291(3): 204-6, 2000 Sep 22.
Article in English | MEDLINE | ID: mdl-10984642

ABSTRACT

Platelet monoamine oxidase B (MAO; EC 1.4.3.4.) activity is stable in the individual and is mainly genetically regulated. Levels of MAO-B in platelets have repeatedly been shown to be associated with personality traits. We have recently also demonstrated an association between the genotype of AP-2beta to a variety of personality traits as well as binge-eating disorder. In the present study we have analysed blood samples from 158 males and 64 females with regard to platelet MAO activity and genotype of transcription factor AP-2beta. In both sexes homozygotes for the long allele [CAAA](5) were significantly associated with low platelet MAO activity P<0.0001 (males) and P=0.0158 (females). This study represents a novel approach to increase the understanding about the molecular mechanisms for how the MAOB gene is regulated in blood cells and how this regulation is linked to personality traits.


Subject(s)
Blood Platelets/enzymology , DNA-Binding Proteins/genetics , Monoamine Oxidase/metabolism , Transcription Factors/genetics , Alleles , Analysis of Variance , Bulimia/enzymology , Bulimia/genetics , Female , Gene Frequency , Genotype , Homozygote , Humans , Male , Sex Factors , Transcription Factor AP-2
10.
Mol Psychiatry ; 5(2): 220-4, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10822354

ABSTRACT

Transcription factor AP-2beta is implicated in playing an important role during embryonic development of different parts of the brain, eg, midbrain, hindbrain, spinal cord, dorsal and cranial root ganglia.1,2 The gene encoding AP-2beta contains a polymorphic region which includes a tetranucleotide repeat of [CAAA] four or five times, located in intron 2 between nucleotides 12593 and 12612.3 Since the midbrain contains structures important for variables such as mood and personality, we have investigated if the AP-2beta genotype is associated with personality traits estimated by the Karolinska Scales of Personality (KSP). Identification of transcription factor genes as candidate genes in psychiatric disorders is a novel approach to further elucidate the genetic factors that, together with environmental factors, are involved in the expression of specific psychiatric phenotypes. The AP-2beta genotype and KSP scores were determined for 137 Caucasian volunteers (73 females and 64 males). The personality traits muscular tension, guilt, somatic anxiety, psychastenia and indirect aggression were significantly associated with the specific AP-2beta genotype, albeit with significant difference between genders. Based on this result the human AP-2beta gene seems to be an important candidate gene for personality disorders. Moreover, the present results suggest that the structure of the intron 2 region of the AP-2beta gene is one factor that contributes to development of the constitutional component of specific personality traits.


Subject(s)
DNA-Binding Proteins/genetics , Personality/genetics , Polymorphism, Genetic , Transcription Factors/genetics , Adult , Aggression , Anxiety/genetics , Female , Hostility , Humans , Introns , Male , Microsatellite Repeats , Personality Assessment , Sweden , Transcription Factor AP-2 , White People
12.
Diabet Med ; 16(6): 514-21, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10391401

ABSTRACT

AIMS: To measure plasma semicarbazide-sensitive amine oxidase (SSAO) activities and detect retinopathy in Type 2 diabetes mellitus (DM). METHODS: Cross-sectional, population-based study of 65 diabetes patients (61 diagnosed from the age of 30 years) with or without retinopathy as determined by fundus photography in primary care. HbA1c was analysed by ion exchange chromatography on a Mono S for HbA1c column. SSAO activities were assayed radiometrically and formaldehyde-albumin adducts by ELISA in plasma samples from patients and 136 healthy controls. RESULTS: Subjects with diabetes had higher plasma SSAO activity, measured as nmol benzylamine x mlplasma(-11) x h(-1)(mean 20.6), than controls (mean 14.3), P<0.0001; 95% confidence interval (CI) for difference 4.9-7.7. SSAO activity was higher in patients with retinopathy (mean 23.2) than in those without (mean 18.9), P=0.012; 95% CI for difference 1.0-7.5, and related to the HbA1c value. No statistically significant relationship between diabetes duration and SSAO activity was found. With HbA1c values and insulin treatment entered into a multiple logistic regression model, SSAO activity no longer predicted retinopathy, P increasing from 0.025 to 0.17. SSAO activity and the presence of any retinopathy were unrelated to titres of antibodies against formaldehyde-treated human serum albumin. CONCLUSIONS: SSAO activity, earlier found to be elevated in Type 1 DM, is also elevated in Type 2 DM. The SSAO family of enzymes may be involved in the development of diabetic retinopathy, possibly by catalysing the formation of toxic metabolites. A potent and specific inhibitor of human SSAO might help prevent retinopathy in Type 1 and Type 2 DM.


Subject(s)
Amine Oxidase (Copper-Containing)/blood , Diabetes Mellitus, Type 2/enzymology , Diabetic Retinopathy/enzymology , Benzylamines/blood , Female , Glycated Hemoglobin/analysis , Humans , Linear Models , Male , Middle Aged
13.
Clin Sci (Lond) ; 97(1): 111-5, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10369802

ABSTRACT

The semicarbazide-sensitive amine oxidases constitute a group of copper-containing enzymes whose physiological function is unclear. The enzymes are present in various tissues, including blood plasma. At present, the source of the plasma enzyme in humans is not known. Results of a recent study suggested that semicarbazide-sensitive amine oxidase is expressed in the skeleton, e.g. in the spine. Using an indirect autoradiographic method in mice, we provide evidence that semicarbazide-sensitive amine oxidase is present in high abundance in bone tissue. Specific activities of semicarbazide-sensitive amine oxidase were estimated in blood samples from subjects with femoral bone fractures. Moreover, enzyme activities were also measured in patients suffering from prostate cancer with skeletal metastases. The level of specific semicarbazide-sensitive amine oxidase activity in serum was significantly elevated in patients with skeletal metastases compared with both healthy controls and patients having prostate cancer without signs of skeletal metastases. Based on the results of the present study, we propose that semicarbazide-sensitive amine oxidase in blood plasma may originate, at least in part, from the skeleton.


Subject(s)
Amine Oxidase (Copper-Containing)/blood , Bone Neoplasms/enzymology , Neoplasm Proteins/blood , Prostatic Neoplasms/enzymology , Semicarbazides/metabolism , Aged , Animals , Autoradiography , Bone Neoplasms/blood , Bone Neoplasms/secondary , Fractures, Spontaneous/blood , Fractures, Spontaneous/enzymology , Humans , Male , Mice , Prostatic Neoplasms/pathology
14.
Eur Neurol ; 41(1): 20-3, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9885324

ABSTRACT

Semicarbazide-sensitive amine oxidase (SSAO) has been suggested to be involved in the development of vascular endothelial damage. The source of the soluble form of SSAO found in the blood serum is unknown. However, it has been speculated that it is secreted from cells within the vascular wall where high activity of the enzyme is found. Altered SSAO activity has been reported in atherosclerotic plaques of the human aorta. Stroke is a manifestation of long-term atherosclerotic disease, and in this study, plasma SSAO activities were estimated in 42 patients with cerebral thrombosis and 26 patients with cerebral embolism, and compared to two control groups of 45 individuals in total. No statistically significant differences were found between the patient groups and controls regarding plasma SSAO activity, suggesting that changes in the soluble form of SSAO found in the circulation do not play a major role in this type of acute cerebrovascular event. Furthermore, it does not seem likely that the involvement of vascular tissue occurring in stroke results in release of the enzyme into the circulation. Nevertheless, further studies on tissue-bound SSAO in cerebral vessels would be of great interest.


Subject(s)
Amine Oxidase (Copper-Containing)/blood , Cerebrovascular Disorders/enzymology , Aged , Aged, 80 and over , Amine Oxidase (Copper-Containing)/antagonists & inhibitors , Arteriosclerosis/enzymology , Endothelium, Vascular/enzymology , Enzyme Inhibitors/pharmacology , Female , Formaldehyde/metabolism , Humans , Intracranial Embolism and Thrombosis/enzymology , Male , Middle Aged , Oxidoreductases Acting on CH-NH Group Donors , Semicarbazides/pharmacology
15.
Life Sci ; 63(9): 759-68, 1998.
Article in English | MEDLINE | ID: mdl-9740313

ABSTRACT

The activity of semicarbazide-sensitive amine oxidase (SSAO) has been reported to be elevated in blood from diabetic patients. It has been suggested that the enzyme is involved in the development of complications such as retinopathies, nephropathies and neuropathies, which are associated with advanced diabetes, possibly by the formation of toxic metabolites. Under the influence of SSAO, methylamine is deaminated to formaldehyde which is known to react with various macromolecules. It has therefore been proposed that specific inhibition of SSAO could be of therapeutic value for treatment of diabetic patients. The present results provide evidence that treatment with an SSAO inhibitor potently reduces the levels of irreversible adducts. In this study, 14C-methylamine was given intraperitoneally to NMRI mice, and the tissue distribution of irreversibly bound methylamine metabolites was estimated by an autoradiographic method. Such radioactive residues occurred in high concentrations in the intestinal wall, brown adipose tissue, spleen and bone marrow. By inhibiting SSAO irreversibly with hydralazine before giving 14C-methylamine to the mice, it was possible to determine the resynthesis rate of SSAO in different tissues. A complete recovery of SSAO activity was seen in the intestinal wall after 6 days, whereas only about 60% was recovered in adipose tissue after 14 days. This suggests that factors controlling the synthesis of SSAO differ in these tissues, or that these tissues express different forms of enzymes.


Subject(s)
Amine Oxidase (Copper-Containing)/metabolism , Autoradiography , Diabetes Mellitus/metabolism , Formaldehyde/metabolism , Methylamines/metabolism , Amine Oxidase (Copper-Containing)/antagonists & inhibitors , Amine Oxidase (Copper-Containing)/biosynthesis , Animals , Deamination , Enzyme Inhibitors/pharmacology , Hydralazine/pharmacology , Male , Mice , Oxidation-Reduction , Oxidoreductases Acting on CH-NH Group Donors/metabolism , Tissue Distribution
16.
J Neural Transm Suppl ; 52: 93-8, 1998.
Article in English | MEDLINE | ID: mdl-9564612

ABSTRACT

Aggregation cultures of rat brain were exposed to a combination of anoxia and hypoglycaemia for 30 minutes. Thereafter, the release of lactate dehydrogenase into the cell culture medium was monitored up to 4 days as a measure of cell damage after the ischemic insult. Some cultures were treated with different concentrations of deprenyl or tolcapone, selective inhibitors of monoamine oxidase B and catechol-O-methyltransferase, respectively. After 1 day in culture, the release of lactate dehydrogenase was significantly reduced in cultures treated with deprenyl (at 1 nM. 100 nM, and 10 microM), as well as in cultures treated with 1 nM or 100 nM tolcapone; 10 microM of tolcapone, on the other hand, resulted in a toxic effect on the cell aggregates. No differences in the release of lactate dehydrogenase into the medium was observed in the aggregates treated with drugs as compared with the control cultures after 2 or 4 days post-ischemia.


Subject(s)
Benzophenones/pharmacology , Cell Survival/drug effects , Enzyme Inhibitors/pharmacology , Monoamine Oxidase Inhibitors/pharmacology , Neurons/cytology , Neuroprotective Agents/pharmacology , Prosencephalon/cytology , Selegiline/pharmacology , Animals , Brain Ischemia , Catechol O-Methyltransferase Inhibitors , Cells, Cultured , Embryo, Mammalian , L-Lactate Dehydrogenase , Models, Neurological , Neurons/drug effects , Nitrophenols , Rats , Rats, Sprague-Dawley , Time Factors , Tolcapone
17.
Neurosci Lett ; 258(2): 101-4, 1998 Dec 18.
Article in English | MEDLINE | ID: mdl-9875537

ABSTRACT

Many studies show that monoamine oxidase B in blood cells is a biological marker for personality characteristics such as sensation seeking. The mechanism underlying this association is so far not explored. In the present study we have performed electrophoretic mobility-shift assays to investigate the pattern of protein binding to a 150 bp fragment of the proximal 5'-flanking region of the human monoamine oxidase B gene. We compared the pattern using nuclear extracts from human brain and lymphocytes. Interestingly, a correlation was observed between monoamine oxidase B enzyme activity in blood cells (platelets) and the binding pattern of two uncharacterized transcription factors. These data are well in line with the long-standing notion that interindividual differences in platelet monoamine oxidase may represent differences in expression of the enzyme rather than genotypic variation.


Subject(s)
Cerebral Cortex/enzymology , Lymphocytes/enzymology , Monoamine Oxidase/genetics , Promoter Regions, Genetic/genetics , Transcription Factors/metabolism , Blood Platelets/metabolism , Cell Nucleus/metabolism , Gene Expression Regulation , Humans , Sp1 Transcription Factor/metabolism
19.
Acta Psychiatr Scand ; 96(4): 295-300, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9350959

ABSTRACT

Human personality characteristics and vulnerability to psychopathology are to a large extent dependent upon genetic factors which have yet to be fully defined. The allele distribution of the dopamine D4 receptor (D4DR) and thrombocyte monoamine oxidase (trbc MAO) activity have both been associated with personality traits which are supposedly related, namely 'sensation seeking' according to Zuckerman and 'novelty seeking' according to Cloninger, respectively. In this report, the D4DR allele distribution and trbc MAO activity were studied in 31 psychiatric patients and 21 control subjects. Trbc MAO activity is a biochemical marker of personality that has been shown to be under strong genetic influence. However, no association between the D4DR alleles and trbc MAO could be observed in this material. To our knowledge, this is the first report comparing these two markers, and based upon the results obtained, we speculate that they may be connected with different types of overlapping personality characteristics. The allele distribution of the tyrosine hydroxylase (TH) gene was also determined. TH is the rate-limiting enzyme in the biosynthesis of catecholamines, and it is believed to be involved in different kinds of psychopathology. No covariation between TH gene alleles and trbc MAO activity or D4DR alleles was observed in this material.


Subject(s)
Alleles , Blood Platelets/enzymology , Monoamine Oxidase/blood , Monoamine Oxidase/genetics , Receptors, Dopamine/genetics , Schizophrenia/genetics , Tyrosine 3-Monooxygenase/genetics , Biomarkers , Catecholamines/biosynthesis , Exons , Female , Genotype , Humans , Male , Monoamine Oxidase/metabolism , Polymorphism, Genetic , Schizophrenia/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL
...